Clinical trials
Completed Erectile Dysfunction trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
105 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 4 |
| 2003 | 7 |
| 2004 | 4 |
| 2005 | 14 |
| 2006 | 5 |
| 2007 | 3 |
| 2008 | 12 |
| 2009 | 7 |
| 2010 | 11 |
| 2011 | 7 |
| 2012 | 2 |
| 2013 | 3 |
| 2015 | 4 |
| 2017 | 2 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 105 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 14 |
| VIVUS LLC | 11 |
| Bayer | 8 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 8 |
| Warner Chilcott | 4 |
| Mayo Clinic | 3 |
| Memorial Sloan Kettering Cancer Center | 3 |
| Coloplast A/S | 2 |
| Duke University | 2 |
| Johns Hopkins University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Erectile Dysfunction | 105 |
| Prostatic Neoplasms | 13 |
| Sexual Dysfunction, Physiological | 6 |
| Hypogonadism | 4 |
| Prostatic Hyperplasia | 3 |
| Urinary Incontinence | 3 |
| Diabetes Mellitus | 2 |
| Lower Urinary Tract Symptoms | 2 |
| Arthritis | 1 |
| Autoimmune Diseases | 1 |
Trials
Showing 1 to 25 of 105. Each trial links to its page on Pharma Observatory.
5 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.